Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Macrocyclic serine protease inhibitors, pharmaceutical compositions thereof, and their use for treating HCV infections

Macrocyclic serine protease inhibitors, pharmaceutical compositions thereof, and their use for treating HCV infections

US Patent 9353100 · Granted May 31, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cyclic phosphate substituted nucleoside derivatives for the treatment of liver d2023
Adenine derivatives as protein kinase inhibitors2022
Carbocyclic nucleoside reverse transcriptase inhibitors2021
Carbocyclic nucleoside reverse transcriptase inhibitors2021
Cyclic phosphate substituted nucleoside compounds and methods of use thereof for2021
Nucleotides for the treatment of cancer2020
Nucleotides for the treatment of cancer2020
2′-chloro nucleoside analogs for HCV infection2019
2′-chloro nucleoside analogs for HCV infection2019
2′-chloro nucleoside analogs for HCV infection2019
Amino acid phosphoramidate pronucleotides of 2′-cyano, azido and amino nucleosid2019
3′-substituted methyl or alkynyl nucleosides nucleotides for the treatment of HC2019